Neuro-Behavioral Clinical Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Alzheimer disease1 trial
• Bipolar disorder1 trial
• Schizophrenia1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• LB Pharmaceuticals Inc.2 trials
• Cognito Therapeutics, Inc.1 trial
• Definium Therapeutics US, Inc.1 trial

Running trials

• Recruiting

  52-week Open Label Safety-Tolerability Study

  NCT07369154· Phase 3· LB Pharmaceuticals Inc.· Source

  Contact: Crystal Blackford

• Recruiting

  Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

  NCT07494305· Phase 2· LB Pharmaceuticals Inc.· Source

  Contact: Crystal Blackford

• Active, not recruiting

  A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

  NCT06941844· Phase 3· Definium Therapeutics US, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bipolar disorder1 recruiting
• Depression1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

  NCT05637801· Cognito Therapeutics, Inc.· Source